Ken Griffin Aprea Therapeutics, Inc. Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

Shares

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 14, 2023	BUY	$0.32 - $15.2 $408 - $19,395	1,276 New	1,276 $0
Q2 2022 Aug 15, 2022	SELL	$0.62 - $1.94 $36,084 - $112,909	-58,201 Reduced 75.51%	18,881 $14,000
Q1 2022 May 16, 2022	SELL	$1.59 - $3.16 $137,024 - $272,325	-86,179 Reduced 52.79%	77,082 $143,000
Q4 2021 Feb 14, 2022	BUY	$2.87 - $5.58 $118,565 - $230,520	41,312 Added 33.88%	163,261 $468,000
Q3 2021 Nov 15, 2021	BUY	$3.43 - $5.63 $320,121 - $525,447	93,330 Added 326.11%	121,949 $623,000
Q2 2021 Aug 16, 2021	BUY	$4.05 - $5.5 $115,906 - $157,404	28,619 New	28,619 $139,000
Q4 2020 Feb 16, 2021	SELL	$4.92 - $30.67 $364,439 - $2.27 Million	-74,073 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$21.66 - $38.86 $5.09 Million - $9.13 Million	-234,875 Reduced 76.02%	74,073 $1.78 Million
Q2 2020 Aug 14, 2020	SELL	$25.47 - $39.69 $313,102 - $487,909	-12,293 Reduced 3.83%	308,948 $12 Million
Q1 2020 May 15, 2020	BUY	$31.65 - $45.3 $387,047 - $553,973	12,229 Added 3.96%	321,241 $11.2 Million
Q4 2019 Feb 14, 2020	BUY	$18.94 - $49.53 $5.85 Million - $15.3 Million	309,012 New	309,012 $14.2 Million

Others Institutions Holding APRE

# of Institutions

2

Shares Held

899

Call Options Held

0

Put Options Held

0

Nbc Securities, Inc. Birmingham, AL

899
Shares

$2,741
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

About Aprea Therapeutics, Inc.

Ticker APRE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Description
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products...

More about APRE

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.